written by reader Hepatitis with a C

by DrKSSMDPhD | June 24, 2014 10:12 pm

Second of Two Parts

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/2014/06/microblog-hepatitis-with-a-c-part-two/


932 responses to “written by reader Hepatitis with a C”

  1. DrKSSMDPhD says:

    I truly don’t want to fan any Hobby Lobby debate as at heart I am quite apolitical. But this is a biotech blog where we often discuss medicine, and I feel it is quite necessary to correct a gross misperception that many defenders of Hobby Lobby have: there seem to be readers here who believe that IUD’s work as abortefacients. This is completely untrue, unsupported by data, and is a quaint outdated notion. IUD’s prevent conception, same as other mainstream methods of contraception. The entire SCOTUS falderal is because Hobby Lobby is science-ignorant (as is often the province of the fervently religious). IUD’s do not cause abortions and do not work by preventing conceptus implantation. The entire premise of this case is nonsense, based on willful misconstrual of facts about how certain anti-pregnancy measures work. Which is why the decision is to be feared, The yardstick should not be arguments about freedom and religion but whether Hobby Lobby’s contentions are in any way rooted in data. They are not.

    Religion freedom should not mean the right of one group to impose its views on another. Vouchsafing defending freedom they have made many of us less free. This decision was the promulgation of an absurdistly business-friendly chief justice who now routinely equates corporations as people when doing so behooves the corporation. Sotomayor is Catholic and voted against the majority. In fact, this was purely a vote along gender lines, which ought to tell you something. Why is it that conservative men think they know so much about and deign themselves to have aegis over women’s bodies?

  2. JoeS says:

    Doc,
    I respect everybody’s opinion, but just as in this court case where there are 2 sides, there are many Dr.’s who would disagree with your assertion about these particular IUD’s. That is why we have a case. I don’t pretend to know anything medically that I haven’t learned from you, but I do know that in a free country, founded for the very purpose of religious freedom, an over-reaching government should not have inserted itself into every ones healthcare. If this were not the case, we would not have a case. Case closed. Until we get the case of the 48oz. Big-Gulps. Gotta Bounce!- getting glared at by wife!

  3. Dan says:

    I don’t pretend to me an expert on the Hobby Lobby case either, but I understand there were something like sixteen contraceptive methods which HL was perfectly okay with, but only four they objected to on religious grounds. I don’t know if they had an objection to IUDs, but understandably, they did object to paying for the so-called “morning after” pill. According to polls, the Hobby Hobby decision was supported by wide majority of Americans who believed this was a clear violation of HL’s Constitutional religious rights.

  4. LongOnLife says:

    My Scottrade account finally updated to the BTEBY shares and they are trading. They show a $25 fee but the local rep promised me that he would remove it. Someone asked earlier about their commissions. They do not charge a foreign transaction fee for the BNIKF shares but you cannot buy BLT shares on line, perhaps you can via the phone. Standard commission otherwise is $7.00, is less than my Schwab account which is $8.95. I have only been using them for a couple of months so I can’t say much about them beyond this.

  5. roblites says:

    TKMR has had their EBOLA RNAi trial temporarily shut down because of participants’
    bad reactions. The company did not precede the trial dosing with an immune suppressor which they had in the past. Some view this as not an RNAi problem because they think at a lesser dose than the current problem level would be effective without the supression because the efficacy would increase w/o the use of this element.
    I must say my jaw dropped for fear of the RNAi world when I first read the headline.

  6. roblites says:

    08:49 AM EDT, 07/07/2014 (MT Newswires) — Analysts at BMO Capital markets have downgraded their rating on biopharmaceutical company Regado BioSciences(RGDO) to underperform from outperform, while setting their price target on the stock at $1 a share. BMO attributed the downgrade to RGDO’s announcement that it has paused the enrollment of its phase 3 REGULATE-PCI trial pending a Data and Safety Monitoring Board review of serious adverse events related to potential allergic reactions. “We are concerned that likelihood of trial termination is relatively high,” the firm said. Shares of RGDO are up 1.42% to $2.85 in today’s pre-market trading, and move within a 52-week range of $2.70 – $14.10.

  7. ptilton45 says:

    Travis, wondering if you could also add a dislike next to the like to give a thumbs down. Maybe enough dislikes would give some a hint that the majority of us don'[t want to read their back and forth commentary that has nothing do with the investment thread, i.e, wine, religion, etc. Thans

  8. lesbaker says:

    RE: post 151 and others on DSCO. Promoted by Larry Smith. Below words lifted from the “MOX Reports”, a long but very interesting article on fake authors and articles.

    “The odd thing here is that Smith gets paid only if the company ends up raising new money when the warrants are exercised. Again, this relationship has remained undisclosed on his website and on Seeking Alpha. It helps to explain his views on non-MDM clients such as Athersys (ATHX), Discovery Labs (DSCO) and Mela Sciences (MELA).

    Smith most recently published strong findings on Discovery Labs on June 13th, 2014 stating: “I continue to recommend purchase of Discovery Laboratories.”

    No free lunch from Smith on Stocks

    SmithOnStocks.com is a “subscription” web site which Mr. Smith runs and where he puts up substantially more content than he does on Seeking Alpha. Mr. Smith charges $29.99 per month to subscribe to this site.

    Despite the subscription charge, much of the detailed content is 100% free to readers.

    Yet “free” is apparently a relative term.

    By analyzing the articles on his site, we can see that the majority of content for MDM clients (such as Northwest) and for his warrant clients (such as Discovery Labs and Athersys) is disseminated forfree, maximizing the distribution.

    The point of all of this is that Smith only initiated coverage on Northwest after he initiated a relationship with MDM. Since that time he has become a prolific writer on Northwest and suddenly on all of MDM’s other small cap biotech clients. The timing coincides perfectly with the creation of new (fake) authors who focus almost exclusively on MDM clients and who can be tied to Redfish.

    Smith has taken deliberate steps to conceal his regulatory background, his IR activities and his relationship with MDM. Yet Smith has also been the loudest and most vocal defender of Northwest Bio against critics who see the company as being promotional and misleading investors. During this time he has been a very vocal and prolific writer on Northwest.”
    The full article is here: http://moxreports.com/author/moxadmin/ mostly on Northwest Bio

  9. nottheboss says:

    Les, thank you for your very useful info on Smith. I had “followed” his articles on SA for a while, and my impression was that his “picks” weren’t doing real well. However, I had no idea about his conflicts. Some articles on SA are instantly recognizable as pumper/basher articles, but Smith just didn’t make my radar go off. Of course, there’s a lot of good articles and comments, too, on SA, so the question is how to spot the less obvious pumper/basher articles for what they are.

  10. eyedoc says:

    Dr.KSS: Are you still long HEB?

  11. danmcco says:

    I've been in and out of $CANF for a quick profit but it looks like its ready to move. They have the QUADfecta of Pharma solutions:

  12. g13man says:

    2019
    noticed 2 different ads for different Hep c cures
    any new news ?
    some one else in the space besides GILD ?
    GILD @ 66.36 today

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.